Welcome to our dedicated page for Ispecimen news (Ticker: ISPC), a resource for investors and traders seeking the latest updates and insights on Ispecimen stock.
iSpecimen Inc. (NASDAQ: ISPC) operates a global technology platform connecting life science researchers with healthcare providers to streamline biospecimen procurement. This page aggregates official company announcements, financial disclosures, and operational updates critical for understanding its role in advancing medical research.
Investors and stakeholders gain real-time access to press releases covering strategic partnerships, regulatory milestones, and marketplace expansions. Key updates include earnings reports, technology innovations like the Next Day Quote program, and collaborations enhancing global specimen availability.
Bookmark this page for timely insights into iSpecimen’s progress in addressing biospecimen sourcing challenges. Regular updates ensure you stay informed about developments impacting oncology research, infectious disease studies, and the company’s growing healthcare network.
iSpecimen (Nasdaq: ISPC), a market leader in providing biospecimens for medical research, announced CEO Tracy Curley's participation at the Aegis Conference from May 2-4, 2023. Curley is scheduled to present on May 4 at 4:30 p.m. ET. The conference will be held virtually, catering to a global audience interested in biospecimen solutions for scientific research.
iSpecimen connects researchers with healthcare specimen providers through its innovative online marketplace, which enables easy access to human biospecimens necessary for medical discovery. The company utilizes proprietary technology that allows users to search for specimens across a vast network of partner healthcare organizations. This strategic engagement at the Aegis Conference highlights iSpecimen's commitment to advancing medical research through improved specimen accessibility.
iSpecimen (Nasdaq: ISPC) announced its financial results for the first quarter ending March 31, 2023, will be reported on May 4, 2023, before market opens. A conference call will be held at 8:30 a.m. ET that day, featuring comments from CEO Tracy Curley. Investors can join the live call by dialing +1-844-826-3033 (U.S. Toll Free) or +1-412-317-5185 (International). The conference call will also be available via audio webcast on iSpecimen's website. A replay of the call will be accessible until May 18, 2023. iSpecimen is a global online marketplace that connects researchers with healthcare specimen providers, aimed at advancing medical research through biospecimen procurement.
iSpecimen reported record quarterly revenue of $3.2 million for Q4 2022, up 28% year-over-year. The company attributed this growth to operational improvements implemented after an in-depth review of its operations.
For the full year 2022, total revenue was approximately $10.4 million, down from $11.1 million in 2021, primarily due to a decrease in COVID-related revenue. Despite a lower cost of revenue, iSpecimen faced increased general and administrative expenses, leading to a net loss of approximately $10.2 million.
The company plans significant investments in technology and strategic initiatives to enhance revenue in 2023.
iSpecimen (Nasdaq: ISPC) has announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, on March 14, 2023, before market opening. The Company will host a conference call at 8:30 a.m. Eastern Time that day, featuring remarks from CEO Tracy Curley. Interested parties can join via phone or web and will have access to a replay until March 28, 2023. iSpecimen connects scientists needing biospecimens with healthcare providers, utilizing a cloud-based platform.
FAQ
What is the current stock price of Ispecimen (ISPC)?
What is the market cap of Ispecimen (ISPC)?
